Financial Consulate’s TG Therapeutics TGTX Stock Holding History

Financial Consulate’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$447	Buy	+8	New	+$433	﹤0.01%	1493

Other funds holding TGTX

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $251M AUM 42.58% 1-Year Est. Return

Financial Consulate's TGTX Position: Q3 2026 in Review

Financial Consulate opened a new position in TG Therapeutics (TGTX) in Q3 2026: 8 shares worth $447. The stake represents ﹤0.01% of the portfolio and ranks #1493 among its holdings.

84 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

Financial Consulate held 8 shares of TG Therapeutics worth $447 as of Q3 2026.
TG Therapeutics was a new Financial Consulate position in Q3 2026.
TG Therapeutics made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1493 holding.
84 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.